In 2003, the German Cancer Society (Deutsche Krebsgesellschaft, DKG) launched a certification program aimed at improving the quality of cancer care.

First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies.

Prior studies suggest that nationally endorsed quality measures for prostate cancer care are not linked closely with outcomes. Using a prospective...

To report our experience and lessons learned as high-volume center of robotic surgery managing patients with prostate cancer since the beginning of...